hexamethylene bisacetamide has been researched along with Granulocytic Leukemia in 11 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, QH | 1 |
| Xie, Y | 1 |
| Fan, HH | 1 |
| Pantazis, P | 2 |
| Bonner, WM | 1 |
| Lazarou, SA | 1 |
| Papadopoulos, NM | 1 |
| Shayo, CC | 1 |
| Mladovan, AG | 1 |
| Baldi, A | 1 |
| Wu, H | 1 |
| Scher, BM | 1 |
| Chu, CL | 1 |
| Leonard, M | 1 |
| Olmedo, R | 1 |
| Scher, GS | 1 |
| Stecker, S | 1 |
| Scher, W | 1 |
| Waxman, S | 1 |
| Hassan, HT | 1 |
| Zyada, LE | 1 |
| Ragab, MH | 1 |
| Rees, JK | 1 |
| Bernstein, SH | 1 |
| Sherman, ML | 1 |
| Hass, R | 1 |
| Nakamura, T | 1 |
| Kharbanda, S | 1 |
| Kufe, DW | 1 |
| Breslow, R | 1 |
| Jursic, B | 1 |
| Yan, ZF | 1 |
| Friedman, E | 1 |
| Leng, L | 1 |
| Ngo, L | 1 |
| Rifkind, RA | 1 |
| Marks, PA | 1 |
| Rowinsky, EK | 1 |
| Donehower, RC | 1 |
| Spivak, JL | 1 |
| Burke, PJ | 1 |
| Griffin, CA | 1 |
| Jones, RJ | 1 |
| Breitman, TR | 1 |
| He, RY | 1 |
| Chun, HG | 1 |
| Leyland-Jones, B | 1 |
| Hoth, D | 1 |
| Shoemaker, D | 1 |
| Wolpert-DeFilippes, M | 1 |
| Grieshaber, C | 1 |
| Cradock, J | 1 |
| Davignon, P | 1 |
| Moon, R | 1 |
| Rifkind, R | 1 |
1 review available for hexamethylene bisacetamide and Granulocytic Leukemia
| Article | Year |
|---|---|
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Line | 1986 |
10 other studies available for hexamethylene bisacetamide and Granulocytic Leukemia
| Article | Year |
|---|---|
HMBA-induced differentiation of myeloid leukemic cell lines is associated with altered G1 cell cycle regulators and related genes.
Topics: Acetamides; Antineoplastic Agents; CD11b Antigen; Cell Differentiation; Cyclin D; Cyclin E; Cyclins; | 2004 |
Specific alterations in the pattern of histone-3 synthesis during conversion of human leukemic cells to terminally differentiated cells in culture.
Topics: Acetamides; Cell Differentiation; Cell Line; Dimethyl Sulfoxide; Histones; Humans; Interphase; Leuke | 1984 |
Isoenzymes of lactate dehydrogenase in human leukemic cells in culture treated with inducers of differentiation.
Topics: Acetamides; Butyrates; Cell Differentiation; Cell Line; Cell Survival; Diamines; Dimethyl Sulfoxide; | 1981 |
Differentiating agents modulate topoisomerase I activity in U-937 promonocytic cells.
Topics: Acetamides; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Carcinogens; Cell Transfor | 1997 |
Reduction in lactate accumulation correlates with differentiation-induced terminal cell division of leukemia cells.
Topics: Acetamides; Animals; Carbon Dioxide; Cell Differentiation; Cell Division; Cell Transformation, Neopl | 1991 |
New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.
Topics: Acetamides; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Drug S | 1991 |
Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells.
Topics: Acetamides; Antigens, Surface; Arachidonic Acid; Arachidonic Acids; Carboxylesterase; Carboxylic Est | 1991 |
Potent cytodifferentiating agents related to hexamethylenebisacetamide.
Topics: Acetamides; Cell Differentiation; Drug Synergism; Erythropoiesis; Humans; Hydroxamic Acids; In Vitro | 1991 |
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.
Topics: Acetamides; Adult; Aged; Bone Marrow; Cell Differentiation; Cell Transformation, Neoplastic; Colony- | 1990 |
Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Topics: Acetamides; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Dimethyl Sulfoxide; Dose-R | 1990 |